Literature DB >> 7590109

Recent advances in pharmacognosy research in China.

Z T Wang1, T B Ng, G J Xu.   

Abstract

1. Progress made in pharmacognostic research by Chinese investigators in the last decade is summarized herein. 2. This review covers studies on herbal properties, resources, identification, physicochemical evaluation, cultivation, breeding, tissue culture, collection, processing, preparation, active principles and pharmacological activities of traditional and herbal Chinese drugs. 3. As a result of these research activities errors in species identification were spotted, new drug resources were revealed, new taxa were discovered, crude drugs were analyzed qualitatively and quantitatively, optimal conditions for cultivation and breeding of plants and animals used as drugs were formulated, the quality of some drugs was controlled, the drug processing procedures and storage conditions were evaluated, and the chemistry and pharmacology of a number of crude drugs were elucidated.

Mesh:

Substances:

Year:  1995        PMID: 7590109     DOI: 10.1016/0306-3623(95)00012-p

Source DB:  PubMed          Journal:  Gen Pharmacol        ISSN: 0306-3623


  2 in total

1.  Honokiol and magnolol increase the number of [3H] muscimol binding sites three-fold in rat forebrain membranes in vitro using a filtration assay, by allosterically increasing the affinities of low-affinity sites.

Authors:  R F Squires; J Ai; M R Witt; P Kahnberg; E Saederup; O Sterner; M Nielsen
Journal:  Neurochem Res       Date:  1999-12       Impact factor: 3.996

Review 2.  Chinese medicines and bioactive compounds for treatment of stroke.

Authors:  Thanasekaran Jayakumar; Antoinet Ramola Elizebeth; Ting-lin Yen; Joen-rong Sheu
Journal:  Chin J Integr Med       Date:  2014-07-10       Impact factor: 1.978

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.